[{"Assets_0_Q3_USD":322436000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":28346000.0,"NetIncomeLoss_1_Q3_USD":5079000.0,"NetIncomeLoss_3_Q3_USD":20279000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":42639000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":42526000.0,"StockholdersEquity_0_Q3_USD":188553000.0,"EarningsPerShareBasic_1_Q3_USD":0.12,"EarningsPerShareBasic_3_Q3_USD":0.48,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]